ATYPICAL TERATOID RHABDOID TUMOUR
Authors: A. I. Bertozzi, C. Munzer, F. Fouyssac, N. Andre, S. Boetto, P. Leblond, F. Bourdeaut, C. Dufour, R. K. Deshpande, K. G. Bhat, S. Mahalingam, A. Muscat, J. Cain, M. Ferguson, D. Popovski, E. Algar, F. J. Rossello, S. Jayasekara, D. N. Watkins, J. Hodge, D. Ashley, M. Hishii, M. Saito, H. Arai, Z. Y. Han, W. Richer, C. Lucchesi, P. Freneaux, A. Nicolas, C. Grison, G. Pierron, O. Delattre, F. Bourdeaut, S. Epari, N. TS, T. Gupta, G. Chinnaswamy, J. G. Sastri, P. Shetty, A. Moiyadi, R. Jalali, T. Fay-McClymont, D. Johnston, L. Janzen, S. Guger, K. Scheinemann, A. Fleming, C. Fryer, J. Hukin, D. Mabbott, A. Huang, E. Bouffet, L. Lafay-Cousin, A. Kawamura, K. Yamamoto, T. Nagashima, K. Bartelheim, M. Benesch, J. Buchner, J. Gerss, M. Hasselblatt, R.-D. Kortmann, G. Fleischack, E. Quiroga, H. Reinhard, R. Schneppenheim, A. Seeringer, R. Siebert, B. Timmermann, M. Warmuth-Metz, I. Schmid, M. C. Fruhwald, M. C. Fruhwald, K. Bartelheim, A. Seeringer, K. Kerl, R.-D. Kortmann, M. Warmuth-Metz, M. Hasselblatt, R. Schneppenheim, R. Siebert, T. Klingebiel, A. Al-Kofide, Y. Khafaga, H. Al-Hindi, M. Dababo, A. Ul-Haq, M. Anas, M. G. Barria, K. Siddiqui, M. Hassounah, M. Ayas, E. Al-Shail, M. Hasselblatt, A. Jeibmann, K. Eikmeier, A. Linge, P. Johann, B. Koos, K. Bartelheim, M. Kool, S. M. Pfister, M. C. Fruhwald, W. Paulus, M. Hasselblatt, U. Schuller, R. Junckerstorff, M. K. Rosenblum, A. H. Alassiri, S. Rossi, K. Bartelheim, I. Schmid, N. Gottardo, H. Toledano, E. Viscardi, L. Witkowski, I. Nagel, F. Oyen, W. D. Foulkes, W. Paulus, R. Siebert, R. Schneppenheim, M. C. Fruhwald, D. Schrey, G. Malietzis, S. Chi, C. Dufour, L. Lafay-Cousin, L. Marshall, F. Carceller, L. Moreno, S. Zacharoulis, R. Bhardwaj, M. Chakravadhanula, V. Ozals, C. Hampton, R. Metpally, P. Grillner, J. Asmundsson, B. Gustavsson, S. Holm, P. D. Johann, A. Korshunov, M. Ryzhova, K. Kerl, T. Milde, O. Witt, D. T. W. Jones, V. Hovestadt, A. Gajjar, M. Hasselblatt, M. Fruhwald, S. Pfister, M. Kool, M. Finetti, A. d. C. Pons, M. Selby, A. Smith, S. Crosier, J. Wood, B. Skalkoyannis, S. Bailey, S. Clifford, D. Williamson, A. Seeringer, K. Bartelheim, K. Kerl, M. Hasselblatt, S. Rutkowski, B. Timmermann, R. D. Kortmann, R. Schneppenheim, M. Warmuth-Metz, J. Gerss, R. Siebert, N. Graf, J. Boos, K. Nysom, M. C. Fruhwald, K. Kerl, N. Moreno, T. Holsten, J. Ahlfeld, J. Mertins, M. Hotfilder, M. Kool, K. Bartelheim, S. Schleicher, R. Handgretinger, M. Fruhwald, M. Meisterernst, K. Kerl, C. Schmidt, J. Ahlfeld, N. Moreno, S. Dittmar, S. Pfister, M. Fruhwald, M. Kool, M. Meisterernst, U. Schuller, G. C. F. Chan, M. M. K. Shing, H. L. Yuen, R. C. H. Li, S. L. Ling, I. Slavc, A. Peyrl, M. Chocholous, A. Azizi, T. Czech, K. Dieckmann, C. Haberler, U. Leiss, G. Gotti, V. Biassoni, E. Schiavello, F. Spreafico, E. Pecori, L. Gandola, M. Massimino, J. Mertins, K. Kornelius, N. Moreno, T. Holsten, M. Fruhwald, M. Kool, M. Meisterernst, H. Yano, N. Nakayama, N. Ohe, M. Ozeki, K. Kanda, T. Kimura, T. Hori, T. Fukao, T. Iwama, A. G. Weil, A. Diaz, J. Gernsback, S. Bhatia, J. Ragheb, T. Niazi, Z. Khatib, K. Kerl, T. Holsten, N. Moreno, A. Zoghbi, a. M. Meisterernst, D. Birks, A. Griesinger, V. Amani, A. Donson, R. Posner, C. Dunham, B. K. Kleinschmidt-DeMasters, M. Handler, R. Vibhakar, N. Foreman, R. Bhardwaj, V. Ozals, C. Hampton, L. Zhou, D. Catchpoole, M. Chakravadhanula, A. Kakkar, A. Biswas, V. Suri, M. Sharma, S. Kale, A. Mahapatra, C. Sarkar, J. Torchia, D. Picard, K. C. Ho, D.-A. Khuong-Quang, L. Louterneau, M. Bourgey, T. Chan, B. Golbourn, L.-L. Cousin, M. D. Taylor, P. Dirks, J. T. Rutka, E. Bouffet, C. Hawkins, J. Majewski, S.-K. Kim, N. Jabado, A. Huang, J. H.-C. Chang, M. Confer, A. Chang, S. Goldman, M. Dunn, W. Hartsell
Journal: Neuro-Oncology (2014)

BACKGROUND: To describe therapeutic approaches in children with atypical Teratoid Rhabdoid Tumours (ATRT) in France.METHODS: Observational study including all children less than 18 years old diagnosed with ATRT in France between 2009 and 2011.RESULTS: Forty seven children were included in this retrospective study.Six patients received no curative treatment while forty-one patients had a curative project.Median age was 1.5 years (range 0-16).The disease was disseminated in 10 patients.Surgical resection was complete in 21 cases.Chemotherapy was administered in 41 children.Twenty-six patients received upfront Vincristine-Methotrexate (5g/m 2 x 3) with intra-thecal Methotrexate, which was stopped in eleven patients: in four cases the disease progressed and in seven cases the toxicities were manageable.Fifteen children received different chemotherapy courses and in four of them the diseases progressed.Eight patients underwent second-look surgery.Radiotherapy was administered in 17 patients at a median time of 19 weeks (13-44) after diagnosis.High-dose chemotherapy (HDCT) was given in 9 children and maintenance therapy in 5 children, starting at respectively 35 and 42 weeks after diagnosis.Median follow-up was 26 months (0.6-47).Median time for progression was 5 months.Two-years overall survival was 32% + /-8%.Median survival was 8 months.DISCUSSION: The survival rate of children with ATRT remains poor, the addition of VM is easily manageable but its benefit remains uncertain.The disease progressed mostly before radiotherapy.Future trials should focus on the delay of radiotherapy and the benefit of HDCT.